ACS Cancer Research Program

More in this category

• Duration of adjuvant therapy for stage III colon cancer: No longer one size fits all
• Adjuvant therapies for biliary tract cancers
• Improving surgical care and outcomes through the OPTI-Surg toolkit
• Surgical management of ADH, ALH, and LCIS
• Clinical trials for surgeons: Hurdles and opportunities
• Present and future cancer staging with the eighth edition of the AJCC Cancer Staging Manual
• Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer
• Preventing colorectal adenomas in cancer survivors: An update on the PACES/S0820 trial
• ACS CRP sponsors educational sessions at Clinical Congress 2017
• Current role of immunotherapy in urologic cancers
• Gastrectomy for cancer: What are the benefits of a minimally invasive approach?
• ACS CRP Dissemination and Implementation Committee issues call for participants in pilot project
• Interventions to promote better conversations about initial treatment for prostate cancer
• Junior investigators: Get engaged in the Alliance for Clinical Trials in Oncology
• In search of the philosopher’s stone: The ALCHEMIST study for lung cancer
• A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy
• Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial
• Second edition of Operative Standards for Cancer Surgery to be published in early 2017
• Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC
• NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer